+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices



Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices



Alimentary Pharmacology and Therapeutics 26(11-12): 1479-1487



Hepatic venous pressure gradient (HVPG) increases significantly after endoscopic therapy in patients with bleeding oesophageal varices, which may precipitate further haemorrhage. Whether vasoactive drugs can suppress these changes remains unknown. To investigate the efficacy of somatostatin when compared with octreotide in preventing the post-endoscopic increase in HVPG during acute bleeding and whether the changes affect outcome. Thirty-three cirrhotics with bleeding varices were randomized to receive somatostatin (n = 17) or octreotide (n = 16) under double-blind conditions, soon after their admission. HVPG measurements were performed before and immediately after endoscopic treatment. In the somatostatin group, postendotherapy HVPG values did not change significantly when compared with pre-treatment values (18.9 vs. 17.2, P = 0.092). Conversely, in the octreotide group, HVPG increased significantly after endoscopy (18.2 vs. 20.8, P = 0.003). The probability of 6-week survival without treatment failure was significantly higher in the somatostatin group (P = 0.024). Post-endoscopic HVPG value was independently associated with 6-week failure. Somatostatin, but not octreotide, effectively prevents the post-endoscopic increase in HVPG, which may be associated with low probability of treatment failure.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 020732445

Download citation: RISBibTeXText

PMID: 17919272

DOI: 10.1111/j.1365-2036.2007.03539.x


Related references

Relationships between the time-course of hepatic venous pressure gradient and the response to endoscopic treatment of varices in cirrhotic patients with acute variceal bleeding. Hepatology 34(4 Pt 2): 535A, October, 2001

Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices. World Journal of Gastroenterology 22(11): 3212-3219, 2017

Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics. Singapore Medical Journal 57(3): 132-137, 2017

Effect of emergency endoscopic ligation and sclerotherapy on portal pressure in cirrhotics with bleeding esophageal varices A randomized single-blind study. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A142, April, 2000

Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Digestive Diseases and Sciences 51(12): 2264-2269, 2006

Hepatic venous pressure gradient predicts early recurrence of varices and rebleeding after endoscopic band ligation. Hepatology 38(4 Suppl 1): 295A, October, 2003

Long-term effects of a slow release somatostatin analogue on hepatic venous pressure gradient in patients with proven esophageal varices. Hepatology 36(4 Part 2): 509A, October, 2002

Long-time effects of a slow release somatostatin analogue on hepatic venous pressure gradient in patients with proven esophageal varices. Journal of Hepatology 38(Supplement 2): 60-61, April, 2003

The effect of emergency endoscopic variceal ligation and sclerotherapy on portal pressure in cirrhotics with bleeding esophageal varices A prospective, randomized single blind study. Hepatology 32(4 Pt 2): 517A, October, 2000

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. Journal of Hepatology 48(2): 229-236, 2007

Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver. Indian Journal of Gastroenterology 28(2): 59-61, 2010

Treatment of acute variceal bleeding by the hepatic venous pressure gradient Preliminary results of a randomized trial. Hepatology 30(4 PART 2): 220A, 1999

Therapeutic effect of somatostatin analog octreotide on esophaged-gastric varices bleeding. Zhonghua Gan Zang Bing Za Zhi 11(3): 152, 2003

Effect of intra venous vasopressin on wedge hepatic pressure and bleeding during esophageal varices hemorrhage. European Journal of Clinical Investigation 9(2 PART 2): 29, 1979

Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!. European Journal of Internal Medicine 22(1): 1-4, 2011